Viral Excretion Among COVID-19 Omicron Recurrence Patients
Sponsor
RenJi Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05470426
Collaborator
(none)
35
1
13
2.7
Study Details
Study Description
Brief Summary
The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
35 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Viral Excretion and Its Influencing Factors Among COVID-19 Omicron Recurrence Patients
Anticipated Study Start Date
:
Jul 1, 2022
Anticipated Primary Completion Date
:
Jul 1, 2023
Anticipated Study Completion Date
:
Aug 1, 2023
Outcome Measures
Primary Outcome Measures
- COVID-19 Omicron Recurrence [Six months]
COVID-19 Omicron Recurrence
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with nucleic acid detection N gene and ORF gene Ct value < 40 after discharge from hospital
-
Being able to provide basic information, living habits, vaccination information, admission information
Exclusion Criteria:
-
Single gene target positive
-
Patients with incomplete baseline data
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Renji Hospital | Shanghai | China | 200123 |
Sponsors and Collaborators
- RenJi Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
RenJi Hospital
ClinicalTrials.gov Identifier:
NCT05470426
Other Study ID Numbers:
- IIT-2022-0102
First Posted:
Jul 22, 2022
Last Update Posted:
Jul 22, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: